December 15, 2025 · Form 4 insider transaction
TRAVERSA SERGIO bought 27,500 shares of Relmada Therapeutics, Inc. at $4.12 per share, a transaction worth $113.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.; Purchase prices range from $4.10 to $4.12 per share, inclusive.